Chemomab Therapeutics Ltd. CMMB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-08-14
Chemomab Therapeutics Ltd. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Mor George Adi | Chief Executive Officer | 2026-05-29 | Buy | 4,878 | $2.05 |
| Mor George Adi | Chief Executive Officer | 2026-05-29 | Buy | 4,926 | $2.08 |
| Mor George Adi | Chief Executive Officer | 2026-05-29 | J | 31,712 | — |
| Mor George Adi | Chief Executive Officer | 2026-05-29 | J | 18,750 | — |
| OrbiMed Israel GP Ltd. | 10% owner | 2023-01-03 | Sell | 266,376 | $3.34 |
| OrbiMed Israel GP Ltd. | 10% owner | 2023-01-03 | Sell | 70,524 | $4.51 |
| Mor George Adi | Chief Scientific Officer | 2023-01-03 | Sell | 7,700 | $5.03 |
| Mor George Adi | Chief Scientific Officer | 2023-01-03 | Sell | 6,100 | $5.03 |
Source: SEC EDGAR filings · CIK 0001534248 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.